NABRIVA THERAPEUTICS FORSCHUNG has a total of 22 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are TRIO MEDICINES LTD, PROD CHIM SA and MUTABILIS SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Israel | 2 | |
#5 | Poland | 2 | |
#6 | China | 1 | |
#7 | Hong Kong | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Slovakia | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Ascher Gerd | 12 |
#2 | Berner Heinz | 7 |
#3 | Heilmayer Werner | 6 |
#4 | Novak Rodger | 5 |
#5 | Thirring Klaus | 4 |
#6 | Paukner Susanne | 4 |
#7 | Mang Rosemarie | 4 |
#8 | Hildebrandt Johannes | 4 |
#9 | Wieser Josef | 3 |
#10 | Schranz Michael | 2 |
Publication | Filing date | Title |
---|---|---|
EP1908750A1 | Process for the preparation of pleuromutilins | |
US2009306203A1 | Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group | |
EP1808431A1 | Mutilin derivatives and their use as pharmaceutical |